Literature DB >> 34297278

Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target interactions.

Sarra Itidal Abbou1, Hafida Bouziane2, Abdallah Chouarfia2.   

Abstract

Identifying drug-target protein association pairs is a prerequisite and a crucial task in drug discovery and development. Numerous computational models, based on different assumptions and algorithms, have been proposed as an alternative to the laborious, costly, and time-consuming traditional wet-lab methods. Most proposed methods focus on separated drug and target descriptors, calculated, respectively, from chemical structures and protein sequences, and fail to introduce and extract features where the interaction information is embedded. In this paper, we propose a new three-step method based on matrix factorisation and generative adversarial network (GAN) for drug-target interaction prediction. Firstly, the matrix factorisation technique is used to capture and extract the joint interaction feature, for both drugs and targets, from the drug-target interaction matrix. Then, a GAN is introduced for data augmentation. It generates a fake positive sample similar to the real positive sample (known interactions) in order to balance the samples, allow the exploitation of the entire negative sample, and increase the data size for an accurate prediction. Finally, a fully connected four-layer neural network is built for classification. Experimental results illustrate a higher prediction performance of the proposed method compared to shallow classifiers and to state-of-the-art methods with an accuracy higher than 97%. Moreover, the data generation effect is confirmed by evaluating the proposed method with and without the generation step. These results demonstrated the efficiency of the latent interaction features and data generation on predicting new drugs or repurposing existing drugs. Overview of the WGANMF-DTI workflow for the Drug-Target Interaction Prediction task.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Deep learning; Drug repurposing; Drug-target interaction (DTI); Generative adversarial networks (GAN); Latent interaction features; Logistic matrix factorisation

Mesh:

Substances:

Year:  2021        PMID: 34297278     DOI: 10.1007/s11030-021-10273-9

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  36 in total

1.  Drug-target interaction prediction by random walk on the heterogeneous network.

Authors:  Xing Chen; Ming-Xi Liu; Gui-Ying Yan
Journal:  Mol Biosyst       Date:  2012-04-26

Review 2.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

3.  Drug discovery: Predicting promiscuity.

Authors:  Andrew L Hopkins
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

Review 4.  Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective.

Authors:  Surovi Saikia; Manobjyoti Bordoloi
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

5.  Relating protein pharmacology by ligand chemistry.

Authors:  Michael J Keiser; Bryan L Roth; Blaine N Armbruster; Paul Ernsberger; John J Irwin; Brian K Shoichet
Journal:  Nat Biotechnol       Date:  2007-02       Impact factor: 54.908

Review 6.  Drug repurposing: progress, challenges and recommendations.

Authors:  Sudeep Pushpakom; Francesco Iorio; Patrick A Eyers; K Jane Escott; Shirley Hopper; Andrew Wells; Andrew Doig; Tim Guilliams; Joanna Latimer; Christine McNamee; Alan Norris; Philippe Sanseau; David Cavalla; Munir Pirmohamed
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

7.  Large-scale prediction and testing of drug activity on side-effect targets.

Authors:  Eugen Lounkine; Michael J Keiser; Steven Whitebread; Dmitri Mikhailov; Jacques Hamon; Jeremy L Jenkins; Paul Lavan; Eckhard Weber; Allison K Doak; Serge Côté; Brian K Shoichet; Laszlo Urban
Journal:  Nature       Date:  2012-06-10       Impact factor: 49.962

8.  QEX: target-specific druglikeness filter enhances ligand-based virtual screening.

Authors:  Masahiro Mochizuki; Shogo D Suzuki; Keisuke Yanagisawa; Masahito Ohue; Yutaka Akiyama
Journal:  Mol Divers       Date:  2018-07-03       Impact factor: 2.943

9.  Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.

Authors:  Himanshu Rai; Atanu Barik; Yash Pal Singh; Akhil Suresh; Lovejit Singh; Gourav Singh; Usha Yogendra Nayak; Vikash Kumar Dubey; Gyan Modi
Journal:  Mol Divers       Date:  2021-02-13       Impact factor: 3.364

10.  Prediction of drug-target interactions and drug repositioning via network-based inference.

Authors:  Feixiong Cheng; Chuang Liu; Jing Jiang; Weiqiang Lu; Weihua Li; Guixia Liu; Weixing Zhou; Jin Huang; Yun Tang
Journal:  PLoS Comput Biol       Date:  2012-05-10       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.